817 reports of this reaction
3.1% of all VALSARTAN AND HYDROCHLOROTHIAZIDE reports
#1 most reported adverse reaction
BLOOD PRESSURE INCREASED is the #1 most commonly reported adverse reaction for VALSARTAN AND HYDROCHLOROTHIAZIDE, manufactured by Novartis Pharmaceuticals Corporation. There are 817 FDA adverse event reports linking VALSARTAN AND HYDROCHLOROTHIAZIDE to BLOOD PRESSURE INCREASED. This represents approximately 3.1% of all 26,234 adverse event reports for this drug.
Patients taking VALSARTAN AND HYDROCHLOROTHIAZIDE who experience blood pressure increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLOOD PRESSURE INCREASED is moderately reported among VALSARTAN AND HYDROCHLOROTHIAZIDE users, representing a notable but not dominant share of adverse events.
In addition to blood pressure increased, the following adverse reactions have been reported for VALSARTAN AND HYDROCHLOROTHIAZIDE:
The following drugs have also been linked to blood pressure increased in FDA adverse event reports:
BLOOD PRESSURE INCREASED has been reported as an adverse event in 817 FDA reports for VALSARTAN AND HYDROCHLOROTHIAZIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLOOD PRESSURE INCREASED accounts for approximately 3.1% of all adverse event reports for VALSARTAN AND HYDROCHLOROTHIAZIDE, making it one of the most commonly reported side effect.
If you experience blood pressure increased while taking VALSARTAN AND HYDROCHLOROTHIAZIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.